iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025

SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies ...
Business Wire

Gilead to Present Late-Breaking Data Highlighting Antiviral Portfolio, Innovative Research Pipeline and HIV Leadership at IDWeek 2024

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new findings from its antiviral research and development programs at IDWeek 2024 ...
Pharmabiz

Lupin to present phase 1 data on LNP3693 at the ESMO Congress 2025

Lupin to present phase 1 data on LNP3693 at the ESMO Congress 2025: Our Bureau, Mumbai Monday, October 13, 2025, 16:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) will pre ...
Nasdaq

BioRestorative Therapies to Present New Preliminary Clinical Data for BRTX-100 at ISSCR 2025 Annual Meeting

BioRestorative Therapies, Inc. announced that it will present new blinded safety and efficacy data from its Phase 2 trial of BRTX-100 for chronic lumbar disc disease (cLDD) at the ISSCR 2025 Annual ...
Morningstar

Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy

VALBY, Denmark, Aug. 25, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced that new data regarding bexicaserin, a novel treatment under investigation for seizures associated with ...